Why Helicobacter Pylori Eradication is Important?

ArticleAçık Erişim

Özet

Background: It was aimed to determine the frequency of Helicobacter pylori (Hp) in patients who were made upper gastrointestinal system endoscopy and antrum biopsy due to dyspeptic complaints and to investigate the relation of Sydney classification criteria with Hp. Materials and Methods: Patients who underwent esophagogastroduodenoscopy and taking antrum biopsy for dyspeptic complaints were included in the study between January 2015 and May 2017 at Ordu University Medical Faculty and Ordu State Hospital Endoscopy Units. Biopsy results of the patients were retrospectively analyzed. Results: The number of the patients was 526. 47.7% (n = 251) of the patients were female and 52.3% (n = 275) were male. The mean age of the cases was 53.65 +/- 16.44 years (min 17 -max 93). 68.1% (n: 358) of the patients were Hp positive and 31.9% (n = 168) were Hp negative. In patients; the results of activation (+) in 75.9% (n: 399), intestinal metaplasia in 15.2% (n = 80) (+), glandular atrophy (+) in 8.6% (n = 45) were observed. All biopsies had inflammation. The severity of Inflammation in cases was 47.53% (n = 250) mild, 41.45% (n = 218) moderate, and 11.02% (n = 58) severe. When we evaluate the relationship between inflammation, activation, intestinal metaplasia and glandular atrophy with Hp, it was observed that all the criteria were significantly higher in patients with Hp (+) than Hp (-). There were severe inflammation in 3 (1.78%) of 168 patients with Hp (-) and 55 (15.4%) of 358 patients with Hp (+) (p:0,000). 320 (89.4%) of the 358 patients with Hp (+) and 79 (47%) of the 168 patients with Hp (-) had activation (p:0,000). Intestinal metaplasia was observed in 63 (17.6%) of the 358 patients with Hp (+) and 17 (10.1%) of 168 patients with Hp(-)(p:0,015). Glandular atrophy was observed in 41 (11.45%) of 358 patients with Hp(+) and in 4 (2.38%) of the 168 patients with Hp (-) (p: 0,000). Conclusion: The prevalence of Hp in the community is still high. In patients with Hp (+), activation, inflammation severity, intestinal metaplasia and glandular atrophy rates are higher than those with Hp (-). Intestinal metaplasia and glandular atrophy are precancerous lesions. Early diagnosis and eradication of Hp may prevent the formation of precancerous lesions. Hp eradication can prevent not only stomach cancer but also many stomach diseases at the same time. Early diagnosis and eradication of Hp is important.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/16925Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.12996/gmj.2019.05Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCinar, Hamza
dc.contributor.authorAkalin, Cagri
dc.contributor.authorKaya, Yasemin
dc.contributor.authorBuyukakincak, Sercan
dc.contributor.authorEken, Huseyin
dc.date.accessioned2026-10-18T20:41:08.684540737Z
dc.date.available2026-10-18T20:41:08.684540737Z
dc.date.issued2019
dc.description.abstractBackground: It was aimed to determine the frequency of Helicobacter pylori (Hp) in patients who were made upper gastrointestinal system endoscopy and antrum biopsy due to dyspeptic complaints and to investigate the relation of Sydney classification criteria with Hp. Materials and Methods: Patients who underwent esophagogastroduodenoscopy and taking antrum biopsy for dyspeptic complaints were included in the study between January 2015 and May 2017 at Ordu University Medical Faculty and Ordu State Hospital Endoscopy Units. Biopsy results of the patients were retrospectively analyzed. Results: The number of the patients was 526. 47.7% (n = 251) of the patients were female and 52.3% (n = 275) were male. The mean age of the cases was 53.65 +/- 16.44 years (min 17 -max 93). 68.1% (n: 358) of the patients were Hp positive and 31.9% (n = 168) were Hp negative. In patients; the results of activation (+) in 75.9% (n: 399), intestinal metaplasia in 15.2% (n = 80) (+), glandular atrophy (+) in 8.6% (n = 45) were observed. All biopsies had inflammation. The severity of Inflammation in cases was 47.53% (n = 250) mild, 41.45% (n = 218) moderate, and 11.02% (n = 58) severe. When we evaluate the relationship between inflammation, activation, intestinal metaplasia and glandular atrophy with Hp, it was observed that all the criteria were significantly higher in patients with Hp (+) than Hp (-). There were severe inflammation in 3 (1.78%) of 168 patients with Hp (-) and 55 (15.4%) of 358 patients with Hp (+) (p:0,000). 320 (89.4%) of the 358 patients with Hp (+) and 79 (47%) of the 168 patients with Hp (-) had activation (p:0,000). Intestinal metaplasia was observed in 63 (17.6%) of the 358 patients with Hp (+) and 17 (10.1%) of 168 patients with Hp(-)(p:0,015). Glandular atrophy was observed in 41 (11.45%) of 358 patients with Hp(+) and in 4 (2.38%) of the 168 patients with Hp (-) (p: 0,000). Conclusion: The prevalence of Hp in the community is still high. In patients with Hp (+), activation, inflammation severity, intestinal metaplasia and glandular atrophy rates are higher than those with Hp (-). Intestinal metaplasia and glandular atrophy are precancerous lesions. Early diagnosis and eradication of Hp may prevent the formation of precancerous lesions. Hp eradication can prevent not only stomach cancer but also many stomach diseases at the same time. Early diagnosis and eradication of Hp is important.
dc.identifier.doi10.12996/gmj.2019.05
dc.identifier.endpage20
dc.identifier.issn2147-2092
dc.identifier.issue1
dc.identifier.startpage17
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/16925
dc.identifier.volume30
dc.identifier.wosWOS:000454502900005
dc.language.isotr
dc.publisherGAZI UNIV, FAC MED
dc.relation.ispartofGAZI MEDICAL JOURNAL
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHelicobacter pylori
dc.subjectSydney classification
dc.subjectprecancerous lesion
dc.subjectINTESTINAL METAPLASIA
dc.subjectGASTRIC-CANCER
dc.subjectATROPHIC GASTRITIS
dc.subjectINFECTION
dc.subjectEPIDEMIOLOGY
dc.subjectPREVALENCE
dc.subjectDIAGNOSIS
dc.subjectASSOCIATION
dc.subjectRISK
dc.subjectMedicine, General & Internal
dc.subjectGeneral & Internal Medicine
dc.titleWhy Helicobacter Pylori Eradication is Important?
dc.typeArticle
dspace.entity.typePublication
rdl.citation.wos0
rdl.oa.statusgold
rdl.source.indexWOS
rdl.wos.indexEmerging Sources Citation Index (ESCI)